Personality Pharmacology

Part IV · Psychopathology on the Same Landscape Draft

Chapter 26

Levels of Disorder

Structural, Molecular, Network, Learned, and Social

Medicine inherited a vocabulary that divides illness into organic and non-organic, biological and psychological, real and functional. The divisions are often practical. They are rarely ontologically clean.

A tumor is obviously physical. A learned fear is also physically instantiated in a brain. A receptor abnormality may be invisible on conventional imaging yet profoundly biological. A delusion has neural correlates and propositional content. A toxic workplace can generate insomnia through social meaning and autonomic physiology simultaneously.

The person does not contain separate psychological and biological universes.

An earlier version of personality pharmacology tried to solve this by distinguishing macroscopic organic disorders, microscopic organic disorders, and non-organic or epistemological disorders. The first two categories were useful. The third was not. If learned beliefs and habits are encoded in neural systems, calling them non-organic reintroduces the dualism the framework is trying to escape.

A better classification is by explanatory level.

At the first level are structural lesions and gross pathology: tumors, strokes, traumatic injuries, neurodegeneration, malformations, or other changes that can be localized anatomically.

At the second are molecular and physiological disturbances: receptor or transporter abnormalities, endocrine disease, inflammatory processes, metabolic disorders, channelopathies, altered neurotransmission, or systemic states that may not be visible on ordinary imaging.

At the third are circuit, network, and computational disturbances: abnormal coupling, impaired inhibition, altered reward learning, unstable arousal, distorted prediction, or failures of integration.

At the fourth are learned policies, habits, beliefs, attachment patterns, and relational adaptations. A person can learn that social approach is dangerous, that alcohol is the fastest route to relief, or that disagreement threatens abandonment.

At the fifth are social and environmental conditions: chronic threat, poverty, coercion, discrimination, impossible workloads, unstable housing, abusive relationships, social isolation, or institutions that repeatedly mismatch the person’s temperament.

These are not competing explanations. They are nested perspectives on one system.

Socialrelationships, work, culture,povertyLearnedbeliefs, habits, conditioned fearNetworkcircuit dynamics, feedback loopsMolecularreceptors, transmitters,inflammationStructurallesions, tumours, development
Figure 26.1Where is the disorder? A disturbance can sit in the brain’s structure, its molecules, its circuits, what has been learned, or the social world, and often in several at once.

Consider anxiety. A person may have a biological disposition toward strong autonomic reactivity, a learned tendency to interpret arousal catastrophically, a habit of avoiding uncertainty, and a job that produces relentless unpredictable demands. A beta-blocker could alter peripheral expression. An SSRI could change affective regulation. Exposure therapy could alter learning. Leaving the job could remove the maintaining environment.

levelin this persona lever at thatlevelBodystrong autonomicreactivitya beta-blocker dampsthe bodily expressionRegulationaffect that is hard toregulatean SSRI changesaffective regulationLearningcatastrophic reading ofarousal, avoidance ofuncertaintyexposure therapychanges the learningEnvironmenta job with relentlessunpredictable demandsleaving the jobremoves whatmaintains it
Figure 26.2One anxiety, several levels. Each level offers its own lever, and none of them is the only real one.

Which treatment is “the real one”?

The question is malformed. The useful intervention is the one that acts on a causal node with acceptable cost.

This layered view allows psychotherapy and pharmacology to coexist without philosophical tension. Psychotherapy is not non-biological because it changes beliefs and behavior. Pharmacology is not deeper merely because it enters through a receptor. Both alter the future state of the same organism through different routes.

It also explains why biological findings do not automatically dictate treatment. A learned fear has synaptic mechanisms, but that does not imply a receptor-targeted intervention is superior to exposure. A social stressor changes cortisol, sleep, and inflammatory signaling, but treating those downstream consequences while preserving the stressor may be less effective than changing the environment.

Reduction can become a category error.

The reverse error is equally common. Calling a condition psychological should not imply voluntariness. Learned adaptations can be automatic, deeply reinforced, and biologically entrenched. A person cannot simply decide that panic no longer feels dangerous because a therapist has explained the mechanism. Learning has to be changed through experience.

The hierarchy also helps interpret personality disorders. A stable pattern of distrust, emotional instability, detachment, or dependency can arise through temperament, development, attachment, trauma, reinforcement, culture, and ongoing relationships. The absence of a discrete lesion does not make the pattern unreal. Nor does its neural implementation make it a simple pharmacological disease.

Personality pathology may be especially likely to span levels because the “disorder” is partly a long-standing strategy for navigating relationships.

This framework creates another ethical guardrail. If the environment is the major causal level, personality pharmacology should not automatically target the person. A worker who cannot tolerate impossible shifts may need a different schedule, not a personality optimized for sleepless compliance. A child overwhelmed by sensory chaos may need environmental adaptation, not simply sedation.

The distinction is political as well as clinical.

The layered model also prepares the later concept of epistemic pathology. A belief system can be maladaptive at the level of learned inference without requiring a specific molecular lesion. Yet it remains physically implemented. The relevant criterion is not whether the belief is “organic”, but how it updates and what maintains it.

The more general principle is explanatory pluralism without ontological dualism. One organism can be described at molecular, computational, psychological, and social levels. The best level depends on the question.

For personality pharmacology, this matters because a drug acts at one level and produces consequences across all the others. A molecule changes receptor activity. The network changes. The person experiences a different state. That state alters behavior. Behavior changes relationships. Relationships create new learning.

A pharmacological perturbation can therefore propagate upward through the hierarchy and feed back down.

A molecule changes receptor activityThe network changesThe person is in a different stateBehaviour changesRelationships changeNew learning feeds back downand downagain
Figure 26.3Up through the levels, and back. A drug acts at one level, and the consequences travel through all the others.

The next chapter examines one outcome where this propagation becomes starkly visible: drug-induced psychosis.